Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
for Alopecia Areata
54 locations incl. Birmingham
Sponsor: Sun Pharmaceutical Industries, Inc.
Sex: All·Age: 12 - 17
Code: NCT07133308·Phase 3·Recruiting